$0.78 0.00 (0%)
2/25/2009 3:42 PM

Replidyne, Inc. (RDYN.DL)

CAPS Rating: No stars

The Company is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products.

Featured Broker Partners